- Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
-
Sánchez-Iglesias ÁL, Morillo-Macías V, Santafé-Jiménez A, Ferrer-Albiach C
- KMID: 2533419
- Radiat Oncol J.
- 2022 Sep;40(3):192-199.
- doi: 10.3857/roj.2022.00101
Purpose: Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer. Materials and Methods: We analysed the toxicity... -
- CITED
-
- Close
- SHARE
-
- Close
